Status:

TERMINATED

Evaluation of the Prosthetic Disc Replacement

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Lumbar Degenerative Disc Disease

Cervical Degenerative Disc Disease

Eligibility:

All Genders

20-65 years

Phase:

NA

Brief Summary

Until now, arthrodesis (intervertebral fusion) is the formal treatment for the lumbar and cervical degenerative disc disease : arthrodesis has been the standard surgical treatment for the patients whe...

Detailed Description

The purpose of this study is to evaluate the cervical and lumbar intervertebral disc replacement by a prosthesis ( arthroplasty ) in adults suffering from degenerative disc disease. For the cervical ...

Eligibility Criteria

Inclusion

  • cervical disc:
  • 20 to 55 years old;
  • symptomatic disc disease between C3-C7 defined as:
  • Cervical or brachial(radicular) pain and/or functional/neurologic deficit with at least one of the following conditions confirmed by imaging :
  • Hernia of the gelatinous core;
  • Spondylosis (osteophytes); loss of height of the disc;
  • Not reacting to the no-invasive treatment or progressive symptoms or compressions ;
  • NDI \>= 15/50;
  • Ready to respect the instructions;
  • More than one vertebral level requiring a treatment;
  • At a vertebral block close to the level to be treated;
  • Associated to a fusion at the adjacent level or another level;
  • Written assent;
  • Patient who can receive one or other treatment;
  • lumbar disc:
  • 25 to 65 years;
  • Symptomatology of prevalent lumbago with or without radiculalgia and failure of the medical treatments;
  • Idiopathic discopathies or after cure of disc herniations (except prior infections);
  • Repetition of disc herniation (except excluded hernia);
  • Discopathies with median posterior disc herniation with limited development and loss of discal height;
  • 1 or 2 contiguous stages or not among L3L4, L4L5, L5S1;
  • Written assent;
  • Patient who can receive one or other treatment;

Exclusion

  • cervical disc:
  • Cervical instability: in flexion/extension Translation \> 3 mm and /or \>11 degrees of rotary difference with one or the other adjacent level;
  • Serious problem of articular facet or degeneration.;
  • Known allergy to cobalt, chromium plates, molybdenum, titanium or polyethylene;
  • Clinically compromised vertebrae at level (s) touched after a current or passed traumatism;
  • Serious spondylosis (MESOCEPHALES osteophytes; loss height of the disc\>70% or Absence of motion(\< 2°));
  • Osteoporosis(DEXA);
  • Paget, osteomalacia or metabolic osseous disturbs ;
  • Serious Willis disease asking an insulin management;
  • Pregnancy;
  • Active, local or generalized infection;
  • Taking treatments or drugs which one knows that they interfere on the management of the bone/ the soft part (e.g. steroids);
  • Rheumatoid arthritis or another disease car-immune;
  • Systemic disease (AIDS, HIV, hepatitis);
  • Active malignity compromising the vital forecast at the short term;
  • Septic antecedents;
  • No-affiliation with the Social Security;
  • Patient refusing to be recontacted by mail or telephone apart from the visits;
  • Patient refusing the randomization;
  • lumbar disc:
  • Morbid Obesity;
  • Abdomen multi operated;
  • Crowned slope L5-S1 high;
  • Traumatic after-effects with moderate deformations of the vertebra ;
  • Symptomatic lumbar canal stenosis;
  • Septic antecedents of the site to be operated;
  • Great degenerative or constitutional vertebral instability ;
  • Narrow lumbar channel and/or excluded and migrated lumbar slipped disc;
  • Scoliosis \>8;
  • Advanced articular osteoarthritis;
  • Severe osteoporosis ;
  • Disease of Paget, Osteomalacia, disturb metabolic osseous;
  • Disease car-immune rheumatoid;
  • Pregnancy;
  • Badly balanced diabetes ;
  • Systemic disease;
  • Vascular Problem (arteritis lower limb, aortic aneurism);
  • Evolutionary Hepatitis ;
  • Immunodeficient Disease (of which HIV);
  • No-affiliation with the Social Security;
  • Patient refusing to be recontacted by mail or telephone apart from the visits;
  • Patient refusing the randomization;

Key Trial Info

Start Date :

February 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2011

Estimated Enrollment :

301 Patients enrolled

Trial Details

Trial ID

NCT00640029

Start Date

February 1 2008

End Date

February 1 2011

Last Update

March 10 2015

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Service de Chirurgie CHU Hopital Antoine Béclère

Clamart, France, 92140

2

Service de Neurochirurgie CHU Saint-Etienne

Saint-Etienne, France